Serology test kit

COVID-19IgGIgM

BioMedomics has developed and launched one of the world’s best rapid point-of-care lateral flow immunoassays to aid in the diagnosis of coronavirus infection. The test detects both early marker and late marker, IgM/IgG antibodies in human finger-prick (capillary) or venous whole blood, serum, and plasma samples. The COVID-19 IgM/IgG Rapid Test by BioMedomics, Inc. demonstrates a combined sensitivity and specificity of 100% and ~99% respectively, making it one of the most accurate and reliable tests in the world There is a critical, global need for serology assays that can complement nucleic acid (PCR) tests for diagnosing COVID-19 infection. Although critically important, PCR tests are only positive during the brief window of acute infection, after which they become negative. And while serology tests are not as effective as PCR early in acute infection, they are able to detect COVID-19 antibodies for a prolonged period of time after disease resolution, which enables identification of prior infection. Knowledge of prior infection is epidemiologically important and represents a significant unmet need in the management of the COVID-19 pandemic. Features & Benefits BioMedomics Rapid IgM-IgG Combined Antibody Test for COVID-19 is used to qualitatively detect IgG and IgM antibodies of the novel coronavirus in human serum, plasma or whole blood in vitro. Steps 1. Collect blood/serum/plasma sample. 2. Add blood/serum/plasma sample to sample well. 3. Place 2-3 drops of buffer in sample well Precise Works with whole blood, serum, & plasma Tests for both IgM and IgG antibodies Validated using PCR Fast Intuitive visual interpretation No special equipment needed